Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D00WZI
|
||||
| Former ID |
DNC014791
|
||||
| Drug Name |
5-methyl-benzo[b]thiophen-2-ylboronic acid
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [1] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C9H9BO2S
|
||||
| Canonical SMILES |
B(C1=CC2=C(S1)C=CC(=C2)C)(O)O
|
||||
| InChI |
1S/C9H9BO2S/c1-6-2-3-8-7(4-6)5-9(13-8)10(11)12/h2-5,11-12H,1H3
|
||||
| InChIKey |
DHNHZPQPQAINDI-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Beta-lactamase | Target Info | Inhibitor | [1] | |
| References | |||||
| REF 1 | J Med Chem. 2007 Nov 15;50(23):5644-54. Epub 2007 Oct 23.Optimizing cell permeation of an antibiotic resistance inhibitor for improved efficacy. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.